# Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study

> **NCT05860400** · — · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 39 (estimated)

## Conditions studied

- Coronary Artery Disease
- Coronary Artery Stenosis
- Coronary Artery Restenosis
- Coronary Artery Disease Progression
- Inflammation
- Inflammatory Disease
- Inflammation Vascular

## Interventions

- **BEHAVIORAL:** Healthy life style
- **DRUG:** Secondary prevention for atherosclerotic coronary artery disease
- **DRUG:** Immunosuppressive therapy
- **PROCEDURE:** Coronary revascularization
- **DRUG:** Supportive therapies

## Key facts

- **NCT ID:** NCT05860400
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-17
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05860400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05860400, "Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05860400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*